News
Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...
A team of researchers in Turkey have discovered multiple signs of stress in the eye after patients took Pfizer's COVID-19 ...
In 2025, food service company Lamb Weston made headlines when its hash brown products had to be pulled from shelves due to a ...
JUUL GETS ITS CROWN — The FDA authorized Juul’s applications on Thursday to sell e-cigarettes in the U.S., determining they’re “appropriate for the protection of public health” because their benefits ...
More than 67,000 cases of deodorant sold at major retailers are being recalled due to a manufacturing issue. According to a ...
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...
NBC News on MSN50m
FDA panel reassesses hormone therapy warnings in menopause treatmentsThe Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have ...
Despite a phase 3 flop, Bristol Myers Squibb—encouraged by “clinically meaningful results” and bruised by three other recent pivotal trial failures—still plans to discuss a potential approval filin | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results